Long-Term Outcomes of Patients With Early Stage Nonbulky Hodgkin Lymphoma Treated With Combined Modality Therapy in the Stanford V Trials (the G4 and G5 Studies)

Overview of attention for article published in International Journal of Radiation Oncology, Biology, Physics, December 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 11 X users

Readers on

mendeley: 28 Mendeley

So far, Altmetric has seen 11 X posts from 11 X users, with an upper bound of 48,204 followers.

We are pleased to welcome @IowaMed grad @emouMD back to @uiowa as faculty after his residency & #HemeOnc fellowship at @StanfordMed. ⬇️ A nice 🧵on his recent publication.

RT @JustinParizo: Really interesting work from @StanfordMedRes legend Dr. Mou. I can only hope to finish fellowship on such a high note. Fe…

RT @emouMD: The Swan Song of Stanford V: Long-Term Outcomes of Patients With Early Stage Nonbulky Hodgkin Lymphoma Treated With Combined Mo…

RT @JustinParizo: Really interesting work from @StanfordMedRes legend Dr. Mou. I can only hope to finish fellowship on such a high note. Fe…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.